Ondřej Kubeček (Ondrej Kubecek)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Pharmaceutics

Clinical & experimental metastasis

Current oncology (Toronto, Ont.)

Cancers

Hradec Kralove University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hradec Kralove University Hospital

Czechia

Senior resident :: Department of Oncology and Radiotherapy

Mayo Clinic Minnesota

United States

Research assistant :: Department of Experimental Medicine and Pathology

Publications

Jindřich Kopecký, Marek Pásek, Radek Lakomy, Bohuslav Melichar, Ivona Mrazová, Ondřej Kubeček, Monika Arenbergerova, Radmila Lemstrová, Alžběta Švancarová, Vojtěch Tretera, Alžběta Hlodáková, Kamila Žváčková
The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting. Cancer medicine 13 (5) (2024)
Ondřej Kubeček, Pavla Paterová, Martina Novosadová
Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors. Life (Basel, Switzerland) 11 (12) (2021)
Ondřej Kubeček, Jan Laco, Jiří Špaček, Alena Kubečková, Jiří Petera, Iva Selke Krulichová, Aleš Bezrouk, Stanislav Filip, Jindřich Kopecký
Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer. Current oncology (Toronto, Ont.) 28 (4) (2021)
Milan Vosmik, Jindřich Kopecký, Stanislav John, Ondřej Kubeček, Petr Lochman, Aml Mustafa Banni, Libor Hruška, Igor Sirák
Combined Therapy of Locally Advanced Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors. Cancers 13 (18) (2021)
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, Miriam Lánská, Milan Bláha
Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940. Pharmaceutics 12 (11) (2020)
Stanislav Filip, Veronika Vymetálková, Jiri Petera, Ludmila Vodickova, Ondřej Kubeček, Stanislav John, Filip Cecka, Marketa Krupova, Monika Manethova, Klara Cervena, Pavel Vodicka
Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review. International journal of molecular sciences 21 (15) (2020)
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, Miriam Lánská, Milan Bláha
Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 12 (10) (2020)
Ondřej Kubeček, Jiřina Martínková, Jaroslav Chládek, Milan Bláha, Jana Maláková, Miroslav Hodek, Jiří Špaček, Stanislav Filip
Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer. Cancer chemotherapy and pharmacology 85 (2) (2019)
Ondřej Kubeček, Jan Laco, Jiří Špaček, Jiří Petera, Jindřich Kopecký, Alena Kubečková, Stanislav Filip
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clinical & experimental metastasis 34 (5) (2017)

Ondřej Kubeček.css-eqlu8i{font-size:small;padding-left:4px;} (Ondrej Kubecek)

Publication Activity (10 Years)

Top Topics

Top Venues

Ondřej Kubeček (Ondrej Kubecek)